MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G Report for Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares
Symbol: CMMB
Shares outstanding: 384M shares
Disclosed Ownership: 32.3M shares
Ownership: 8.4%
Form type: SCHEDULE 13G
Filing time: 07 Aug 2025, 11:45:36 UTC
Date of event: 30 Jun 2025
Next filing: 07 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	8.4%	32.3M	0	32.3M	Christopher O'Hara	Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC	7.5%	28.8M	0	28.8M	Christopher O'Hara	Authorized Signatory, Morgan Stanley & Co. LLC